Milestone reached in new leukemia drug

(Cold Spring Harbor Laboratory) Using a chemical compound called YKL-05-099, a team of cancer researchers from CSHL and the Dana Farber Institute was able to target the Salt-Inducible Kinase 3 (SIK3) pathway and extend survival in mice with MLL leukemia.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news